» Articles » PMID: 38466776

Computationally Inferred Cell-type Specific Epigenome-wide DNA Methylation Analysis Unveils Distinct Methylation Patterns Among Immune Cells for HIV Infection in Three Cohorts

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2024 Mar 11
PMID 38466776
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Epigenome-wide association studies (EWAS) have identified CpG sites associated with HIV infection in blood cells in bulk, which offer limited knowledge of cell-type specific methylation patterns associated with HIV infection. In this study, we aim to identify differentially methylated CpG sites for HIV infection in immune cell types: CD4+ T-cells, CD8+ T-cells, B cells, Natural Killer (NK) cells, and monocytes.

Methods: Applying a computational deconvolution method, we performed a cell-type based EWAS for HIV infection in three independent cohorts (Ntotal = 1,382). DNA methylation in blood or in peripheral blood mononuclear cells (PBMCs) was profiled by an array-based method and then deconvoluted by Tensor Composition Analysis (TCA). The TCA-computed CpG methylation in each cell type was first benchmarked by bisulfite DNA methylation capture sequencing in a subset of the samples. Cell-type EWAS of HIV infection was performed in each cohort separately and a meta-EWAS was conducted followed by gene set enrichment analysis.

Results: The meta-analysis unveiled a total of 2,021 cell-type unique significant CpG sites for five inferred cell types. Among these inferred cell-type unique CpG sites, the concordance rate in the three cohorts ranged from 96% to 100% in each cell type. Cell-type level meta-EWAS unveiled distinct patterns of HIV-associated differential CpG methylation, where 74% of CpG sites were unique to individual cell types (false discovery rate, FDR <0.05). CD4+ T-cells had the largest number of unique HIV-associated CpG sites (N = 1,624) compared to any other cell type. Genes harboring significant CpG sites are involved in immunity and HIV pathogenesis (e.g. CD4+ T-cells: NLRC5, CX3CR1, B cells: IFI44L, NK cells: IL12R, monocytes: IRF7), and in oncogenesis (e.g. CD4+ T-cells: BCL family, PRDM16, monocytes: PRDM16, PDCD1LG2). HIV-associated CpG sites were enriched among genes involved in HIV pathogenesis and oncogenesis that were enriched among interferon-α and -γ, TNF-α, inflammatory response, and apoptotic pathways.

Conclusion: Our findings uncovered computationally inferred cell-type specific modifications in the host epigenome for people with HIV that contribute to the growing body of evidence regarding HIV pathogenesis.

Citing Articles

Sex differences in epigenetic ageing for older people living with HIV.

Johnston C, Pang A, Siegler E, Thomas C, Burchett C, Crowley M EBioMedicine. 2025; 113:105588.

PMID: 39923742 PMC: 11849644. DOI: 10.1016/j.ebiom.2025.105588.

References
1.
Bogoi R, de Pablo A, Valencia E, Martin-Carbonero L, Moreno V, Vilchez-Rueda H . Expression profiling of chromatin-modifying enzymes and global DNA methylation in CD4+ T cells from patients with chronic HIV infection at different HIV control and progression states. Clin Epigenetics. 2018; 10:20. PMC: 5812196. DOI: 10.1186/s13148-018-0448-5. View

2.
Silverberg M, Lau B, Achenbach C, Jing Y, Althoff K, DSouza G . Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med. 2015; 163(7):507-18. PMC: 4711936. DOI: 10.7326/M14-2768. View

3.
Suzuki K, Okuno Y, Kawashima N, Muramatsu H, Okuno T, Wang X . MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents. J Clin Oncol. 2016; 34(28):3451-9. DOI: 10.1200/JCO.2016.66.5547. View

4.
Wu V, Nordin J, Nguyen S, Joy J, Mampe F, Del Rio Estrada P . Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4 T cell reservoir. Nat Immunol. 2022; 24(2):359-370. PMC: 9892009. DOI: 10.1038/s41590-022-01371-3. View

5.
Wei X, Walia V, Lin J, Teer J, Prickett T, Gartner J . Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet. 2011; 43(5):442-6. PMC: 3161250. DOI: 10.1038/ng.810. View